These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6295428

  • 1. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
    Twentyman PR.
    Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
    [Abstract] [Full Text] [Related]

  • 2. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR.
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.
    Yuhas JM, Spellman JM, Jordan SW, Pardini MC, Afzal SM, Culo F.
    Br J Cancer; 1980 Oct; 42(4):574-85. PubMed ID: 6254555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
    Clement JJ, Johnson RK.
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(3-4):539-42. PubMed ID: 6286550
    [Abstract] [Full Text] [Related]

  • 9. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
    Honess DJ, Bleehen NM.
    Br J Radiol; 1985 Jan; 58(685):63-72. PubMed ID: 4063642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS, Nelson NJ, Mahler P, Anderson K, Krohn KA, Menard T.
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [Abstract] [Full Text] [Related]

  • 14. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D, Altschuler EM, Hunter N, Milas L.
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK, Walden TL, Hughes HN, Jackson WE.
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I clinical trials of WR-2721 with alkylating agent chemotherapy.
    Glick JH, Glover DJ, Weiler C, Blumberg A, Nelson D, Yuhas JM, Kligerman M.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(3-4):575-80. PubMed ID: 6286556
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.